Numinus CEO Payton Nyquvest Says Psychedelic Therapy Shouldn’t Be The ‘Last’ Option For Treatment Nov 21, 2021
With 3 Granted Patents and 41 Pending, Small Pharma Is On Track To Be One Of Europe’s Biggest Psychedelic Companies Nov 19, 2021
Braxia CEO Dr. McIntyre Looks To Establish Framework For Psychedelic Therapeutic Advancement Nov 19, 2021
Synthesized Non-Hallucinogenic LSD Puts BetterLife Pharma on Psychedelic Investors Radar Nov 18, 2021
